People · Operator
Named in public records as an officer, director or promoter · active 2008–2025 · Other Health Care, Other Technology, Mining & Resources, Computers, Biotechnology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Alere Inc. | — | Other Health Care | Series D+ | $500.0M | $9.2B | 2009 |
| Wispry Inc | — | Other Technology | Series B | $61.5M | $243.6M | 2009 |
| SeeQC, Inc. | — | Other Technology | Series B | $46.8M | $87.8M | 2019 |
| Peek Inc | — | Other Technology | Series A | $20.6M | $17.4M | 2009 |
| Applied Minerals, Inc. | — | Mining & Resources | Series A | $19.5M | $4.0M | 2008 |
| goTenna, Inc. | — | Other Technology | Series A | $16.3M | $208.1M | 2015 |
| theScore, Inc. | — | Other Technology | Series A | $9.0M | $249.7M | 2019 |
| Onpath Technologies Inc | — | Computers | Seed | $4.5M | $40.8M | 2009 |
| Evogen, Inc. | — | Biotechnology | Seed | $1.9M | $37.9M | 2010 |
| Optimist, Inc. | — | Other | Pre-Seed | $931K | $21.5M | 2019 |
John Levy at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Levy on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jonathan Leitersdorf | 3 | 4 |
| Oded Weiss | 2 | 4 |
| Albert Wenger | 1 | 20 |
| PAUL CONLEY | 1 | 17 |
| Jeffrey Samberg | 1 | 14 |
| David Scott | 1 | 12 |
| Larry Marcus | 1 | 10 |
| John Albright | 1 | 9 |
| Amol Sarva | 1 | 6 |
| Will Porteous | 1 | 6 |
| RON ZWANZIGER | 1 | 6 |
| Benjamin Levy | 1 | 5 |
| John Peterson | 1 | 4 |
| John Quelch | 1 | 4 |
| Brian Mitchell | 1 | 4 |
| Jason Whitmire | 1 | 3 |
| Paul A. Conley | 1 | 3 |
| Jonathan Bloch | 1 | 3 |
| Sean Reineke | 1 | 3 |
| RON GERATY | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.